Article

Genetic disruption of WASHC4 drives endo-lysosomal dysfunction and cognitive-movement…

eLife · 2021 · Jamie L Courtland, author Tyler WA Bradshaw, author Greg Waitt, author Erik J Soderblom, author Tricia Ho, author Anna Rajab, author Ricardo Vancini, author Il Hwan Kim, author ([email protected]) Scott H Soderling, author ([email protected]) Hugo J Bellen, editor Huda Y Zoghbi, senior_editor

Key facts

Title Genetic disruption of WASHC4 drives endo-lysosomal dysfunction and cognitive-movement impairments in mice and humans
First author Jamie L Courtland, author Tyler WA Bradshaw, author Greg Waitt, author Erik J Soderblom, author Tricia Ho, author Anna Rajab, author Ricardo Vancini, author Il Hwan Kim, author ([email protected]) Scott H Soderling, author ([email protected]) Hugo J Bellen, editor Huda Y Zoghbi, senior_editor
Journal eLife
Published Mar 22, 2021
DOI 10.7554/eLife.61590
Devices mentioned K010696, K033489, K040471, K040782, K833921, K873601, K912245, K922285, K984054
Product codes mentioned CEK, FZO, FZX, GDJ, HTJ, HTO, HTW, HWP, HWT, HXX, JIT, JWH and 6 more

At a glance

  • 1–9 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature